| Literature DB >> 31431828 |
Allison Gordon1, Zankhana Buch2, Vanessa Baute1, Remy Coeytaux1.
Abstract
BACKGROUND: Ayurveda is an ancient medicine practice that is emerging in the United States as a complementary and alternative treatment for chronic illness. Type 2 diabetes is a chronic illness that has major long-term implications for individuals suffering from the disease as well as the health-care system as a whole. Modifications in diet, exercise, and lifestyle are all important factors in successful treatment of type 2 diabetes and are incorporated into the ancient Indian medicinal practice of Ayurveda.Review Summary: This review summarizes the available evidence for the use of Ayurvedic therapies in the treatment of type 2 diabetes. For the treatment of type 2 diabetes, Ayurvedic practices primarily emphasizes the use of herbal supplements; however, exercise, weight management, and various supplemental procedures are included in Ayurvedic practices. The goal of Ayurvedic practices on the treatment of type 2 diabetes like in Western medicine focuses on bringing the hemoglobin A1c (HbA1c) value into a therapeutic range. Where Ayurveda differs is that it looks at the functionality of a person in the context of striking a balance between the life forces or doshas that each individual possesses. Finally, this article includes a case study received from AyurVAID clinic in Bangalore, India that details the specific Ayurvedic intervention used in a patient, bringing his HbA1c from a level of 11.2 to 5.7 over the course of 9 months.Entities:
Keywords: Ayurveda; Ayurvedic; diabetes; diet; lifestyle; type 2 diabetes mellitus
Year: 2019 PMID: 31431828 PMCID: PMC6686320 DOI: 10.1177/2164956119861094
Source DB: PubMed Journal: Glob Adv Health Med ISSN: 2164-9561
Patient Laboratory Results.
| Lab Investigations | 11/15/15 | 11/29/15 | 12/22/15 | 02/03/15 | 04/12/15 | 07/12/15 |
|---|---|---|---|---|---|---|
| Before Consultation at AyurVAID | On the First Day of Ayurveda Treatment | At the End of Ayurveda Inpatient Treatment | Fourth-Month Review Status | Sixth-Month ReviewStatus | Ninth-Month Review Status | |
| Oral hypoglycemic agents | ||||||
| Tab. Dianorm M | 1-0-1 | 1-0-1 | Nil | Nil | Nil | Nil |
| FBS (mg/dL) | 211 | 113 | 106 | 100 | 93 | 90 |
| FUS (mg/dL) | 1+ | Nil | Nil | Nil | Nil | Nil |
| PPBS (mg/dL) | NA | 139 | 138 | — | 120 | 113 |
| Mean glucose (mg/dL) | 274.74 | 260.39 | 194 | 147 | — | 116.89 |
| HbA1c (%) | 11.20 | 10.7 | 8.4 | 6.7 | 5.8 | 5.7 |
Abbreviations: FBS, fasting blood sugar; FUS, fasting urine sugar; HbA1c, hemoglobin A1c; NA, not applicable; PPBS, postprandial blood sugar.
Patient’s Clinical Outcome.
| Clinical Outcome Measures | 11/24/15 | 12/22/15 | 07/12/16 |
|---|---|---|---|
| Physiological status | |||
| Coating on tongue | Present (P) | Absent (A) | Absent(A) |
| Excessive eating (snacking) | Present | Absent | Absent |
| Weight (kg) | 86 | 84 | 78 |
| BMI | 27.76 | 27.12 | 24.54 |
| Lethargy | Present | Present | Absent |
| Loss of concentration | Present | Absent | Absent |
| Blurred vision | Present | Present | Absent |
| Numbness in big toes | Present | Absent | Absent |
Abbreviation: BMI, body mass index.
| From Date | To Date | Procedure | Treatment Medicines |
|---|---|---|---|
| 11/29/15 | 12/05/15 | Udwartanam | Triphaladi choornam + Kolakulathadi choorna in dhanyamla paste |
| 11/29/15 | 12/05/15 | Dhanyamladhara | Dhanyamla |
| 12/06/15 | 12/10/15 | Snehapanam | Triphala ghrita |
| 12/11/15 | 12/14/15 | Abhyanga+Bashpasweda | Body—Mahavishagarbha taila and head—Balaguduchyadi taila |
| 12/12/15 | 12/12/15 | Vamanam | Yashtimadhu phanta—3L, Madanaphala yoga—1 g, and milk—3L |
| 12/14/15 | 12/14/15 | Virechanam | Avipatti choorna—20 g with hot water |
| 12/15/15 | 12/22/15 | Yogavasti | K.V-Erandamoola kashaya 300 mL + Tilataila 150 mL + Honey 150 mL + Shatapushpa kalka 25 g + Madanaphala 10 g + Shilajatu 5 g, A.V-Nimbamritadi erandam 100 mL + Shilajatu 1 g |
| 12/15/15 | 12/22/15 | Shirodhara | Balaguduchyadi taila |